Seattle biotechs part of race for cancer vaccine

05/16/2005 | Seattle Times, The

Two biotechnology companies headquartered in Seattle are engaged in the industry race to develop a vaccine for cancer, a competition in which some competitors claim to be within a year of achieving the goal. Dendreon and Xcyte Therapies are among the biotech companies that believe a vaccine for cancer is reachable as early as next year.

View Full Article in:

Seattle Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health